How COVID Might Sow Chaos in the Brain
SARS-CoV-2 appears to travel widely across the cerebral cortex
Headaches, hallucinations, vivid dreams, smell & taste anomalies, strokes and seizures
80% of COVID patients encountered neurological complications
How COVID Might Sow Chaos in the Brain
SARS-CoV-2 appears to travel widely across the cerebral cortex
Headaches, hallucinations, vivid dreams, smell & taste anomalies, strokes and seizures
80% of COVID patients encountered neurological complications
Limbic system damage from Covid:
SARS-CoV-2 is a neurotropic virus that may cause long-term neurological symptoms by damaging the limbic system.
This research shows that COVID-19 can impair emotion recognition, memory, and olfactory abilities, with altered brain connectivity patterns.
“COVID-19 survivors show signs of significant cognitive deficits which could become dementia even a year after having the virus.. The team [in India] found that more than 80% of people tested reported at least one of four symptoms – depression, anxiety, stress and insomnia – ranging from mild to severe.. At least 6.1% of the patients were diagnosed with mild cognitive impairment and 4% developed dementia. More than 60% of the patients experienced a loss of taste and smell during the active phase of the infection. This could alter the function of brain areas linked to cognitive ability and emotional well-being.."
More loss of smell and taste, insomnia and pronounced anxiety are new symptoms of latest Covid variant as the virus continues to mutate unrestrained, is neuroinvasive, persists in the body and has multiple effects on the brain:
SARS2 can invade your brain.
All variants are neuroinvasive.
Neuroinvasion and anosmia are independent phenomena upon infection.
SARS2 can travel retrogradely and anterogradely along axons in neuron-epithelial networks.
Starting thread on potential treatments for anosmia / parosmia (loss of/altered smell & taste) "Randomized clinical trial olfactory dysfunction after COVID-19: olfactory rehabilitation therapy vs. intervention treatment w/ Palmitoylethanolamide & Luteolin"
"Roughly 5% of people who experience smell loss during COVID-19 will develop long-term anosmia, according to Dr. Bradley J. Goldstein, an ear, nose and throat doctor at Duke University Hospital.
The impact is more drastic than most people realize."